These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29853741)

  • 1. Both Educational Lectures and Reference Photographs Are Necessary to Improve the Accuracy and Reliability of Psoriasis Area and Severity Index (PASI) Assessment: Results from Korean Nation-Wide PASI Educational Workshop.
    Choi CW; Kim BR; Park JS; Youn SW
    Ann Dermatol; 2018 Jun; 30(3):284-289. PubMed ID: 29853741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The reliability of three psoriasis assessment tools: Psoriasis area and severity index, body surface area and physician global assessment.
    Bożek A; Reich A
    Adv Clin Exp Med; 2017 Aug; 26(5):851-856. PubMed ID: 29068583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of Inter-Rater and Intra-Rater Variability in Psoriasis Area and Severity Index Assessment by Photographic Training.
    Youn SW; Choi CW; Kim BR; Chae JB
    Ann Dermatol; 2015 Oct; 27(5):557-62. PubMed ID: 26512170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A study examining inter-rater and intrarater reliability of a novel instrument for assessment of psoriasis: the Copenhagen Psoriasis Severity Index.
    Berth-Jones J; Thompson J; Papp K;
    Br J Dermatol; 2008 Aug; 159(2):407-12. PubMed ID: 18565187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment.
    Berth-Jones J; Grotzinger K; Rainville C; Pham B; Huang J; Daly S; Herdman M; Firth P; Hotchkiss K
    Br J Dermatol; 2006 Oct; 155(4):707-13. PubMed ID: 16965419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters.
    Armstrong AW; Parsi K; Schupp CW; Mease PJ; Duffin KC
    JAMA Dermatol; 2013 May; 149(5):577-82. PubMed ID: 23426158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three methods for measuring psoriasis severity in clinical studies (Part 1 of 2): change during therapy in Psoriasis Area and Severity Index, Static Physician's Global Assessment and Lattice System Physician's Global Assessment.
    Chow C; Simpson MJ; Luger TA; Chubb H; Ellis CN
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1406-14. PubMed ID: 25917315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rethinking the Psoriasis Area and Severity Index: the impact of area should be increased.
    Jacobson CC; Kimball AB
    Br J Dermatol; 2004 Aug; 151(2):381-7. PubMed ID: 15327545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artificial Intelligence-Based Psoriasis Severity Assessment: Real-world Study and Application.
    Huang K; Wu X; Li Y; Lv C; Yan Y; Wu Z; Zhang M; Huang W; Jiang Z; Hu K; Li M; Su J; Zhu W; Li F; Chen M; Chen J; Li Y; Zeng M; Zhu J; Cao D; Huang X; Huang L; Hu X; Chen Z; Kang J; Yuan L; Huang C; Guo R; Navarini A; Kuang Y; Chen X; Zhao S
    J Med Internet Res; 2023 Mar; 25():e44932. PubMed ID: 36927843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intra- and interobserver variability of image-based PASI assessments in 120 patients suffering from plaque-type psoriasis.
    Fink C; Alt C; Uhlmann L; Klose C; Enk A; Haenssle HA
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1314-1319. PubMed ID: 29569769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision and reproducibility of automated computer-guided Psoriasis Area and Severity Index measurements in comparison with trained physicians.
    Fink C; Alt C; Uhlmann L; Klose C; Enk A; Haenssle HA
    Br J Dermatol; 2019 Feb; 180(2):390-396. PubMed ID: 30218575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why statistics matter: limited inter-rater agreement prevents using the psoriasis area and severity index as a unique determinant of therapeutic decision in psoriasis.
    Gourraud PA; Le Gall C; Puzenat E; Aubin F; Ortonne JP; Paul CF
    J Invest Dermatol; 2012 Sep; 132(9):2171-5. PubMed ID: 22592157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).
    Mahil SK; Wilson N; Dand N; Reynolds NJ; Griffiths CEM; Emsley R; Marsden A; Evans I; Warren RB; Stocken D; Barker JN; Burden AD; Smith CH;
    Br J Dermatol; 2020 May; 182(5):1158-1166. PubMed ID: 31286471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment.
    Langley RG; Ellis CN
    J Am Acad Dermatol; 2004 Oct; 51(4):563-9. PubMed ID: 15389191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is Clear Always Clear? Comparison of Psoriasis Area and Severity Index (PASI) and the Physician's Global Assessment (PGA) in Psoriasis Clearance.
    Wu AG; Conway J; Barazani L; Roy B; Cline A; Pereira F
    Dermatol Ther (Heidelb); 2020 Oct; 10(5):1155-1163. PubMed ID: 32804321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-observer reliability of the PASI in a clinical setting.
    Cabrera S; Chinniah N; Lock N; Cains GD; Woods J
    Australas J Dermatol; 2015 May; 56(2):100-2. PubMed ID: 25753553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Product of the Physician Global Assessment and body surface area: a simple static measure of psoriasis severity in a longitudinal cohort.
    Walsh JA; McFadden M; Woodcock J; Clegg DO; Helliwell P; Dommasch E; Gelfand JM; Krueger GG; Duffin KC
    J Am Acad Dermatol; 2013 Dec; 69(6):931-7. PubMed ID: 24054760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The self-administered psoriasis area and severity index is valid and reliable.
    Feldman SR; Fleischer AB; Reboussin DM; Rapp SR; Exum ML; Clark AR; Nurre L
    J Invest Dermatol; 1996 Jan; 106(1):183-6. PubMed ID: 8592072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Image-based remote evaluation of PASI scores with psoriasis by the YOLO-v4 algorithm.
    Yin H; Chen H; Zhang W; Zhang J; Cui T; Li Y; Yu N; Yu Y; Long H; Xiao R; Su Y; Li Y; Zhang G; Tan Y; Wu H; Lu Q
    Exp Dermatol; 2024 Apr; 33(4):e15082. PubMed ID: 38664884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index).
    Faria JR; Aarão AR; Jimenez LM; Silva OH; Avelleira JC
    An Bras Dermatol; 2010; 85(5):625-9. PubMed ID: 21152786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.